Director/PDMR Shareholding
Polar Capital Global Healthcare Trust plc (the "Company")
Legal Entity Identifier: 549300YV7J2TWLE7PV84
Notification of Transactions by Persons Discharging Managerial Responsibilities (PDMRs)/Persons Closely Associated (PCAs)
The Company was notified on 11 June 2026 that Stacey Parrinder-Johnson, a Non-executive Director, bought 5,250 Ordinary Shares of 25p each for her personal holding at the aggregate price of 419.025 pence per share. Following this transaction, Ms. Parrinder-Johnson is interested in a total of 10,000 Ordinary Shares representing approximately 0.01% of the Company's issued share capital.
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Stacey Parrinder-Johnson
2
Reason for the notification
a)
Position/status
Non-executive Director
b)
Initial notification /Amendment
Initial Notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Polar Capital Global Healthcare Trust plc
b)
LEI
549300YV7J2TWLE7PV84
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Ordinary Shares of 25p each
Identification code
GB00B6832P16
b)
Nature of the transaction
Purchase
c)
Price(s) and volume(s)
Price(s)
Volume(s)
419.025 pence per share
5,250
d)
Aggregated information
Single transaction as in 4 c) above
- Aggregated volume
5,250
- Price
£21,998.81
e)
Date of the transaction
11 June 2026
f)
Place of the transaction
London Stock Exchange (XLON)
Enquiries:
Tracey Lago, FCG
Company Secretary
Polar Capital Global Healthcare Trust plc
Telephone Number: 020 7227 2700
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.ENDDSHBDGDLGGBDGLB
